Cancer incidence in Indians from three areas: Delhi and Mumbai, India, and British Columbia, Canada.

Background: Studies of immigrants have provided unique opportunities for examining disparities in cancer screening and the impact of lifestyles and environmental exposures on cancer risk. Findings have been useful for planning cancer control strategies and generating etiological hypotheses. Although India is a leading source of immigration to British Columbia (BC), Canada, little is known about the cancer profiles of Indo-Canadians, information needed for planning health services and health promotion initiatives for this population.

Population-based survival from cancers of breast, cervix and ovary in women in Mumbai, India.

Background: Breast, cervix and ovarian cancers contribute more than 45% of the total in women in Mumbai and survival proportions for these neoplasms are very high in most developed populations in the World. The authors here report and discuss the population-based survival for these cancers in Mumbai, India.

Methods: Follow-up information on 4865 cancers of breast, cervix and ovary, registered in the Mumbai Population Based Cancer Registry for the period 1992-1994 was obtained by a variety of methods, including matching with death certificates from the Mumbai vital statistics registration system, postal/telephone enquiries, home visits and scrutiny of medical records.

Population-based survival from cancers having a poor prognosis in Mumbai (Bombay), India.

Background: Oesophagus, stomach, pancreas and lung cancers contribute more than 35% of the total cancer incidence in Mumbai and survival rates for these cancers are very poor in most populations in the world. The authors here report and discuss the population-based survival from these cancers in Mumbai, India.

Methods: Follow-up information on 5717 cancers patients having a low prognosis, registered in the Mumbai Population-Based Cancer Registry for the period 1987-1991, was obtained by a variety of methods, including matching with death certificates from the Mumbai vital statistics registration system, postal/telephone enquiries, home visits and scrutiny of medical records.

An Assessment of Improvement in Reliability and Completeness of Mumbai Cancer Registry Data from 1964-1997.

The Mumbai Cancer Registry was established in 1964 with the aim of obtaining reliable morbidity and mortality data from precisely defined urban population. It was first and only such registry for merely two decades functioning in the country. Up to now more than 200,000 cancer cases are registered and with over 100,000 cancer deaths are recorded in data files.

An Assessment of Cancer Incidence Patterns in Parsi and Non Parsi Populations, Greater Mumbai.

The Mumbai Cancer Registry has been in operation since 1964 and reliable morbidity and mortality data on cancer have been obtained for the first time in India, from a precisely outlined population. An attempt has been made to examine the differences noticed in the site-specific cancer risk, between two groups of people living in this area-the Parsi and non Parsi population of Mumbai. For this study, data has been utilized, collected by Mumbai Cancer Registry for the latest five years.

Retinoblastoma: An Epidemiological Appraisal with Reference to a Population in Mumbai, India.

Reliable data on incidence and mortalityfor childhood cancers are available from only a few areas in the developing countries. Neoplasia in children is rare as compared with adult cancer. In Europe, North America and Australia, retinoblastomas account for 2-4 percent of the total and the relative frequency is similar in Asia.

Cancer in Women in Mumbai, India.

The challenge of population based cancer registration in developing countries is enormous. In India, the first Population Based Cancer Registry named "Bombay Cancer Registry" was established by the Indian Cancer Society in Mumbai (formerly Bombay) in 1963, covering the population of the Mumbai Agglomeration. Up to now this registry has collected epidemiological information on more than 200,000 cancer incidence cases and 100,000 cancer deaths.